Lapuerta Pablo 4

4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2019

Form 4

Period: 2019-02-28

SVP, Clin Dev and CMO

Transactions

Exercise/Conversion
Common Stock
2019-02-28+2,585→ 45,337 total
Exercise/Conversion
Restricted Stock Units
2019-02-28−4,550→ 0 total
→ Common Stock (4,550 underlying)
Exercise/Conversion
Common Stock
2019-02-28+4,227→ 42,752 total
Tax Payment
Common Stock
2019-02-28$5.51/sh−6,809$37,518→ 47,098 total
Exercise/Conversion
Common Stock
2019-02-28+4,550→ 38,525 total
Exercise/Conversion
Common Stock
2019-02-28+8,570→ 53,907 total
Exercise/Conversion
Restricted Stock Units
2019-02-28−4,227→ 4,228 total
→ Common Stock (4,227 underlying)
Exercise/Conversion
Restricted Stock Units
2019-02-28−8,570→ 17,140 total
→ Common Stock (8,570 underlying)
Exercise/Conversion
Restricted Stock Units
2019-02-28−2,585→ 5,170 total
→ Common Stock (2,585 underlying)

Footnotes (6)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
[F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
[F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
[F4]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
[F5]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
[F6]Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.

Documents

1 file